[
  {
    "ts": "2025-07-22T15:56:33+00:00",
    "headline": "Why Are Charles River Laboratories (CRL) Shares Soaring Today",
    "summary": "Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 7.5% in the morning session after the company announced a plasmid DNA manufacturing agreement with Elly's Team, a parent-led foundation working to find a cure for a rare genetic disorder.",
    "url": "https://finance.yahoo.com/news/why-charles-river-laboratories-crl-155633683.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "f3f74a0f-afdf-3d1e-856a-553e5c265ec3",
      "content": {
        "id": "f3f74a0f-afdf-3d1e-856a-553e5c265ec3",
        "contentType": "STORY",
        "title": "Why Are Charles River Laboratories (CRL) Shares Soaring Today",
        "description": "",
        "summary": "Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 7.5% in the morning session after the company announced a plasmid DNA manufacturing agreement with Elly's Team, a parent-led foundation working to find a cure for a rare genetic disorder.",
        "pubDate": "2025-07-22T15:56:33Z",
        "displayTime": "2025-07-22T15:56:33Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "CRL Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PLZRbui545u2bOcqTkunEw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YlRDliezLyxJ3r.biO59fw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/7509c571642c6ae9d1577bc3c4457c17.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-charles-river-laboratories-crl-155633683.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-charles-river-laboratories-crl-155633683.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-22T12:00:00+00:00",
    "headline": "Charles River Joins Elly’s Team to Drive Rare Disease Gene Therapy Development",
    "summary": "WILMINGTON, Mass., July 22, 2025--As part of Charles River’s Cell & Gene Therapy Accelerator Program, Elly’s Team manufactured critical starting materials for a Phase I clinical trial.",
    "url": "https://finance.yahoo.com/news/charles-river-joins-elly-team-120000116.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "29a94d4b-3890-3d65-a03c-ebe402a665f4",
      "content": {
        "id": "29a94d4b-3890-3d65-a03c-ebe402a665f4",
        "contentType": "STORY",
        "title": "Charles River Joins Elly’s Team to Drive Rare Disease Gene Therapy Development",
        "description": "",
        "summary": "WILMINGTON, Mass., July 22, 2025--As part of Charles River’s Cell & Gene Therapy Accelerator Program, Elly’s Team manufactured critical starting materials for a Phase I clinical trial.",
        "pubDate": "2025-07-22T12:00:00Z",
        "displayTime": "2025-07-22T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/da1747df1246a07ab5fd9ca0a0d6bf83",
          "originalWidth": 480,
          "originalHeight": 321,
          "caption": "Elly’s Team is a faith-based foundation established with a singular goal of translating medical research to treatment in record time. Their path to treatment involves funding additional research to understand the disease mechanism and effects on the body, developing and manufacturing drugs, navigating the FDA approval process and clinical trials, and treating children. To learn more, visit ellysteam.org.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TZL9p9vR8RQhJgb5ieoW5g--~B/aD0zMjE7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/da1747df1246a07ab5fd9ca0a0d6bf83.cf.webp",
              "width": 480,
              "height": 321,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a67yt0_kWV9m8teDS.wmJg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/da1747df1246a07ab5fd9ca0a0d6bf83.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-joins-elly-team-120000116.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-joins-elly-team-120000116.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]